Wellington Management Group LLP Syndax Pharmaceuticals Inc Transaction History

Wellington Management Group LLP

$557 Billion
Q3 2024

A detailed history of Wellington Management Group LLP transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Wellington Management Group LLP holds 4,985,976 shares of SNDX stock, worth $80.3 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

4,985,976

Previous 7,339,004 32.06%

Holding current value

$80.3 Million

Previous $151 Million 36.3%

% of portfolio

0.02%

Previous 0.03%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$17.93 - $24.81 $42.2 Million - $58.4 Million	-2,353,028 Reduced 32.06%	4,985,976 $96 Million
Q2 2024 Aug 13, 2024	SELL	$18.82 - $23.79 $1.84 Million - $2.32 Million	-97,612 Reduced 1.31%	7,339,004 $151 Million
Q1 2024 May 15, 2024	BUY	$19.71 - $24.57 $147 Million - $183 Million	7,436,616 New	7,436,616 $177 Million
Q4 2023 Feb 12, 2024	BUY	$11.39 - $21.67 $86.4 Million - $164 Million	7,585,221 New	7,585,221 $164 Million
Q3 2023 Nov 14, 2023	BUY	$14.52 - $21.77 $2.88 Million - $4.32 Million	198,262 Added 2.66%	7,642,446 $111 Million
Q2 2023 Aug 14, 2023	BUY	$19.35 - $22.31 $8.52 Million - $9.83 Million	440,450 Added 6.29%	7,444,184 $156 Million
Q1 2023 May 12, 2023	SELL	$20.66 - $28.98 $20.2 Million - $28.4 Million	-979,708 Reduced 12.27%	7,003,734 $148 Million
Q4 2022 Feb 13, 2023	BUY	$20.64 - $26.24 $74.2 Million - $94.4 Million	3,596,002 Added 81.96%	7,983,442 $203 Million
Q3 2022 Nov 14, 2022	BUY	$18.51 - $24.79 $21.9 Million - $29.3 Million	1,180,574 Added 36.81%	4,387,440 $105 Million
Q2 2022 Aug 15, 2022	BUY	$13.64 - $19.48 $18.7 Million - $26.7 Million	1,372,936 Added 74.86%	3,206,866 $61.7 Million
Q1 2022 May 16, 2022	BUY	$14.84 - $22.15 $3.49 Million - $5.21 Million	235,164 Added 14.71%	1,833,930 $31.9 Million
Q4 2021 Feb 11, 2022	SELL	$15.23 - $22.47 $1.19 Million - $1.75 Million	-78,093 Reduced 4.66%	1,598,766 $35 Million
Q3 2021 Nov 15, 2021	BUY	$13.87 - $19.8 $567,671 - $810,374	40,928 Added 2.5%	1,676,859 $32 Million
Q2 2021 Aug 16, 2021	SELL	$13.42 - $25.18 $18 Million - $33.7 Million	-1,339,061 Reduced 45.01%	1,635,931 $28.1 Million
Q1 2021 May 17, 2021	BUY	$19.28 - $24.59 $6.93 Million - $8.84 Million	359,549 Added 13.75%	2,974,992 $66.5 Million
Q4 2020 Feb 12, 2021	SELL	$15.1 - $26.44 $10.8 Million - $18.9 Million	-715,125 Reduced 21.47%	2,615,443 $58.2 Million
Q3 2020 Nov 16, 2020	SELL	$13.39 - $17.48 $5.71 Million - $7.45 Million	-426,180 Reduced 11.34%	3,330,568 $49.2 Million
Q2 2020 Aug 14, 2020	BUY	$8.94 - $20.98 $6.77 Million - $15.9 Million	757,119 Added 25.24%	3,756,748 $55.7 Million
Q1 2020 May 14, 2020	SELL	$6.65 - $12.03 $293,005 - $530,053	-44,061 Reduced 1.45%	2,999,629 $32.9 Million
Q4 2019 Feb 11, 2020	BUY	$5.43 - $9.22 $16.5 Million - $28.1 Million	3,043,690 New	3,043,690 $26.7 Million

Others Institutions Holding SNDX

# of Institutions

227

Shares Held

88.3M

Call Options Held

1.01M

Put Options Held

692K

View Full List

About Syndax Pharmaceuticals Inc

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $911M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

More about SNDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Account

Wellington Management Group LLP Syndax Pharmaceuticals Inc Transaction History